Delivery Order SPE2DB24D1205-SPE2DB25FCYVB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation has an ultimate completion date of September 16, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a firm fixed price structure. This non-set-aside competitive award was announced on August 18, 2025, with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77, with completion expected by April 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $11,187.56. The award was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count package) on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Calquence is a prescription oncology medication used in the treatment of certain blood cancers,...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with an ultimate completion date of October 6, 2025. This is a competitive, non-set-aside award issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on September 3, 2025, with a ceiling value of $11,187.56 and an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYVBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-competitive set-aside delivery order was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. As a child contract, this award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's delivery orders under the SPE2DX contract demonstrate consistent capability to meet federal requirements through open competition, with transaction values ranging from under $100 to over $45,000. This particular award for Calquence, a specialty oncology medication, reflects the company's role in supporting military and veteran healthcare supply chains through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/23/25 |